使用凯泽分数作为乳腺损伤分类的临床决策规则:计算机辅助曲线类型分析能否改善诊断?
N Pötsch1, G Vatteroni2, P Clauser1
1Department of Biomedical Imaging and Image-guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
European journal of radiology
|January 7, 2024
概括
乳腺MRI的凯泽得分 (KS) 是强大的,因为它的诊断性能不受增强曲线类型的评估方式的影响. 这证实了它在所有乳腺病变的常规临床实践中的可靠性.
科学领域:
- 放射学 放射学是一门学科.
- 医疗成像医学成像
- 在瘤学瘤学.
背景情况:
- 凯泽评分 (KS) 是一种临床决策规则,用于乳腺MRI评估恶性瘤风险.
- 精确评估增强曲线类型对于KS的性能至关重要.
- 对增强曲线的视觉评估可能是主观的.
研究的目的:
- 评估增强曲线类型的自动 (参数图) 或视觉评估是否会影响乳房MRI中凯泽分数 (KS) 的诊断性能.
- 为了确定KS的稳定性,无论增强曲线评估方法如何.
主要方法:
- 从1.5T乳腺MRI扫描 (2013-2015) 中对220个乳腺病变 (BI-RADS 0,4或5) 的回顾性分析.
- 凯泽分数标准包括,SI时间曲线类型,边缘,内部增强和.
- 增强曲线类型由两名放射科医生通过视觉和像素智能参数图进行评估.
- 使用ROC分析对诊断性能进行了比较.
主要成果:
- 在视觉和参数地图评估之间没有发现KS诊断绩效的显著差异 (AUC0.875与0.901,P=0.119).
- 在这两种方法中,灵敏度和特异性仍然很高 (视觉:95%/63%;地图:97%/65%).
- 对质量和非质量病变的单独分析也显示,评估方法之间没有显著差异.
结论:
- 凯泽评分的诊断性能在很大程度上独立于增强曲线类型评估方法 (视觉与自动).
- 这证实了凯泽评分作为常规实践中乳腺MRI临床决策规则的稳定性和可靠性.
- 该KS可可靠地应用于所有乳腺损伤类型.
相关概念视频
Kaplan-Meier Approach
148
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
148
Receiver Operating Characteristic Plot
189
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
189
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195


